Use Santarus to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Santarus will likely underperform.
The median price of Santarus for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 20.2 with a coefficient of variation of 7.71. The daily time series for the period is distributed with a sample standard deviation of 1.54, arithmetic mean of 19.97, and mean deviation of 1.35. The Stock received substential amount of media coverage during this period.
Santarus Inc [SNTS] is traded on NASDAQ in USA. It is located in Santarus, Inc.San Diego, CA and employs 290 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.2 B. Santarus Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 63.91 M outstanding shares of which 3.07 M shares are at this time shorted by private and institutional investors with about 3.3 trading days to cover.
Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary solutions that address the needs of patients treated by physician specialists. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory